呼吁将医疗保险D部分配方与喘临床治疗指南保持一致
Amelia Lao1, Anusha McNamara2, Lenny Lok Shun Chan3
1School of Pharmacy, University of California, San Francisco.
Journal of managed care & specialty pharmacy
|February 6, 2025
概括
医疗保险D部分计划经常限制使用全球指南推的首选喘吸入器. 将配方剂与指导方针对齐,可以改善患者的治疗结果和遵守标准护理喘管理.
科学领域:
- 肺部病理学 肺部病理学
- 卫生政策 卫生政策
- 药物经济学 药物经济学
背景情况:
- 全球喘倡议的指导方针建议吸入的皮质类固醇-formoterol用于喘管理.
- 这种疗法减少了喘恶化和住院治疗,相比单独使用短效缓解剂.
- 目前的医疗保险D部分计划设计可能与这些基于证据的建议不一致.
研究的目的:
- 评估医疗保险D部分配方与全球喘倡议指南的协调程度.
- 确定患者获得建议的喘维持和缓解疗法的障碍.
- 为改善喘护理而倡导修改表格.
主要方法:
- 对医疗保险D部分计划表单的审查.
- 基于凯泽家庭基金会报告的分析.
- 与当前国际喘管理指南相比,表单设计的比较.
主要成果:
- 许多医疗保险D部分计划的表单设计限制了使用推的吸入性皮质类固醇-形式醇吸入器的机会.
- 这种 misalignment 限制了处方者遵守已建立的喘指南.
- 患者面临着对标准护理喘治疗的限制.
结论:
- 医疗保险D部分表单设计对最佳喘管理构成了重大障碍.
- 优先考虑吸入性皮质类固醇-formoterol疗法作为首选药物至关重要.
- 在医疗保险D部分计划中最大限度地降低准入障碍可以改善喘患者的临床结果.
更多相关视频
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
216
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
216
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Antiasthma Drugs: β2-Adrenoceptor Agonists
231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
233
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
233
Drugs Used in Lower Respiratory Disorders: Overview
344
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
344


